M. Pehlivan Et Al. , "Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.," Endocrine, metabolic & immune disorders drug targets , vol.21, pp.925-931, 2021
Pehlivan, M. Et Al. 2021. Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.. Endocrine, metabolic & immune disorders drug targets , vol.21 , 925-931.
Pehlivan, M., Nursal, A., Gündeş, İ., Oyacı, Y., Kıvanç, D., & Pehlivan, S., (2021). Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.. Endocrine, metabolic & immune disorders drug targets , vol.21, 925-931.
Pehlivan, M Et Al. "Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.," Endocrine, metabolic & immune disorders drug targets , vol.21, 925-931, 2021
Pehlivan, M Et Al. "Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.." Endocrine, metabolic & immune disorders drug targets , vol.21, pp.925-931, 2021
Pehlivan, M. Et Al. (2021) . "Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.." Endocrine, metabolic & immune disorders drug targets , vol.21, pp.925-931.
@article{article, author={M Pehlivan Et Al. }, title={Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.}, journal={Endocrine, metabolic & immune disorders drug targets}, year=2021, pages={925-931} }